#targeted therapy — Tuesday, May 19, 2026 (1 items)
| 0 | 💬 0 |
Overcoming ADC resistance in advanced colorectal cancer by dual targeting of TROP2 and PERK to suppress Wnt/beta-catenin signaling.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-05-19 | #amr #cancer #signaling #targeted therapy #combination therapy |